T. Rowe Price Associates
DBD icon

T. Rowe Price Associates’s Diebold Nixdorf DBD Stock Holding History

T. Rowe Price Associates’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69M Buy
31,630
+4,491
+17% +$361K ﹤0.01% 1868
2026
Q1 		$2.05M Buy
27,139
+4,269
+19% +$314K ﹤0.01% 1813
2025
Q4 		$1.55M Sell
22,870
-586
-2% -$36.6K ﹤0.01% 1873
2025
Q3 		$1.34M Buy
23,456
+974
+4% +$57.7K ﹤0.01% 1931
2025
Q2 		$1.25M Buy
22,482
+1,266
+6% +$59.4K ﹤0.01% 1877
2025
Q1 		$928K Buy
21,216
+11,422
+117% +$498K ﹤0.01% 1996
2024
Q4 		$422K Buy
9,794
+1,459
+18% +$65.7K ﹤0.01% 2359
2024
Q3 		$373K Buy
+8,335
New +$345K ﹤0.01% 2378

Other funds holding DBD

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $368M AUM 57.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates's DBD Position: Q2 2026 in Review

T. Rowe Price Associates increased its Diebold Nixdorf (DBD) stake by 17% in Q2 2026, buying an estimated $361K and bringing the position to 31,630 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1868.

T. Rowe Price Associates first reported a position in DBD in Q3 2024 and has held it in 8 quarters since. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • T. Rowe Price Associates held 31,630 shares of Diebold Nixdorf worth $2.69M as of Q2 2026.
  • T. Rowe Price Associates bought 4,491 Diebold Nixdorf shares in Q2 2026, an estimated $361K.
  • Diebold Nixdorf made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1868 holding.
  • T. Rowe Price Associates first reported a position in Diebold Nixdorf in Q3 2024 and has held it in 8 quarters since.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.